Skip to main content
An official website of the United States government
Email

Troy McEachron

A photo of a man, Dr. Troy McEachron, who standing in a lab, smiling at the camera, and wearing glasses and a lab coat.

Dr. Troy McEachron aims to enhance outcomes in young patients with osteosarcoma and advocates for broader representation in clinical trials.

Credit: National Cancer Institute

Investigator, Pediatric Oncology Branch at NCI

Motivated by challenging questions and personal experiences, Dr. Troy McEachron's (he/him) journey into pediatric oncology began with a pivotal realization: children are not just small adults, and their diseases require unique approaches. Now focusing on osteosarcoma, the most common bone tumor in young patients, he's dedicated to improving patient outcomes and increasing participation of underrepresented populations in research.

Data sharing is crucial to this work. "Sharing data allows us to transcend limitations of individual research efforts," Troy said. "By pooling our collective knowledge, we gain a more comprehensive understanding of the disease landscape, enabling us to identify commonalities and differences across diverse patient populations."

Troy emphasized that data sharing extends beyond collaboration—it’s significant in shaping the future of pediatric oncology, and he sees data as the cornerstone of progress in understanding and treating childhood cancers.

Outside the lab, Troy enjoys photography, balancing long-term research with moments of instant gratification.

Sign up to get stories like this and CCDI updates in your inbox

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Troy McEachron was originally published by the National Cancer Institute.”

Email